Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
Chin J Integr Med. 2012 Aug;18(8):571-4. doi: 10.1007/s11655-012-1186-8. Epub 2012 Aug 2.
Nowadays, a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China. When great attention is paid to using TCPM in the real world, several problems can be identified: ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation, a lack of appropriate dosage and usage based on individual patient conditions, and a shortage of evidence from randomized, double-blind, placebo-controlled clinical trials. Furthermore, in terms of evaluation of the TCPM effectiveness, few comprehensive criteria and evaluation methods recognized by the international community exist. This article addresses some opinions regarding the above mentioned problems.
如今，大量的中药（TCM）在中国被越来越广泛地用于治疗脑梗死。当大家都非常关注在真实世界中使用 TCM 时，我们可以发现几个问题：忽视基于辨证论治的中医药治疗原则，缺乏根据个体患者情况制定的合适剂量和用法，以及缺乏随机、双盲、安慰剂对照临床试验的证据。此外，在评价 TCM 的有效性方面，目前还没有国际社会认可的全面标准和评价方法。本文针对上述问题提出了一些意见。
